Mylan

Dimethyl fumarate delayed-release capsules are indicated for the treatment of relapsing forms of multiple sclerosis (MS)

Pretomanid is only the third new anti-tuberculosis (TB) drug developed specifically for drug-resistant forms of the disease to be…

According to figures compiled by the CDSCO, India will be producing 20,000 vials per day by the end of July. 

The company also launched a 24/7 helpline number to give out information about the availability of the drug

Announcement follows Mylan shareholder approval of Mylan’s combination with Pfizer’s Upjohn. Viatris is a new company that will be…

Measures include constant monitoring of the drug’s usage and ensuring its uninterrupted supply by working in collaboration with…

Mylan will manufacture remdesivir in India at its injectables facilities, which also make product for the US.

Many also allude to an emerging black market for remdesivir in the country through which the drug is being sold at exorbitant…

Jubilant, BDR and Dr Reddy's Labs have also awaiting permission from CDSCO to manufacture and market the drug in India and are…

Informs that it is awaiting data on some crucial parameters from companies that have applied for manufacturing and marketing…